company background image
2487 logo

Cutia Therapeutics SEHK:2487 Stock Report

Last Price

HK$6.06

Market Cap

HK$1.8b

7D

-1.1%

1Y

-75.6%

Updated

23 Jun, 2024

Data

Company Financials +

2487 Stock Overview

An investment holding company, engages in the research, development, manufacture, and commercialization of scalp diseases and care products, and skin care products in the People’s Republic of China and Hong Kong.

2487 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth2/6
Past Performance0/6
Financial Health4/6
Dividends0/6

Cutia Therapeutics Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Cutia Therapeutics
Historical stock prices
Current Share PriceHK$6.06
52 Week HighHK$31.00
52 Week LowHK$5.57
Beta0
11 Month Change-23.77%
3 Month Change-29.53%
1 Year Change-75.56%
33 Year Changen/a
5 Year Changen/a
Change since IPO-72.39%

Recent News & Updates

A Look At The Intrinsic Value Of Cutia Therapeutics (HKG:2487)

Jun 03
A Look At The Intrinsic Value Of Cutia Therapeutics (HKG:2487)

Analysts Are Betting On Cutia Therapeutics (HKG:2487) With A Big Upgrade This Week

Apr 08
Analysts Are Betting On Cutia Therapeutics (HKG:2487) With A Big Upgrade This Week

Recent updates

A Look At The Intrinsic Value Of Cutia Therapeutics (HKG:2487)

Jun 03
A Look At The Intrinsic Value Of Cutia Therapeutics (HKG:2487)

Analysts Are Betting On Cutia Therapeutics (HKG:2487) With A Big Upgrade This Week

Apr 08
Analysts Are Betting On Cutia Therapeutics (HKG:2487) With A Big Upgrade This Week

Shareholder Returns

2487HK BiotechsHK Market
7D-1.1%-2.5%0.6%
1Y-75.6%-33.0%2.4%

Return vs Industry: 2487 underperformed the Hong Kong Biotechs industry which returned -33% over the past year.

Return vs Market: 2487 underperformed the Hong Kong Market which returned 2.4% over the past year.

Price Volatility

Is 2487's price volatile compared to industry and market?
2487 volatility
2487 Average Weekly Movement7.3%
Biotechs Industry Average Movement9.0%
Market Average Movement7.1%
10% most volatile stocks in HK Market15.1%
10% least volatile stocks in HK Market3.7%

Stable Share Price: 2487's share price has been volatile over the past 3 months.

Volatility Over Time: 2487's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2019298Lele Zhangwww.cutiatx.com

Cutia Therapeutics an investment holding company, engages in the research, development, manufacture, and commercialization of scalp diseases and care products, and skin care products in the People’s Republic of China and Hong Kong. It focuses on the dermatology treatment and care therapeutic areas, including localized adipose accumulation management medication, scalp diseases and care, skin diseases and care, and topical anesthesia. The company’s products include CU-40102, a topical finasteride spray approved for androgenetic alopecia treatment; CU-10201, a topical 4% minocycline foam, approved for acne vulgaris treatment; and CU-10101, a topical novel small molecule agent, and a non-hormonal and small molecule drug for the treatment of mild to moderate atopic dermatitis.

Cutia Therapeutics Fundamentals Summary

How do Cutia Therapeutics's earnings and revenue compare to its market cap?
2487 fundamental statistics
Market capHK$1.85b
Earnings (TTM)-HK$2.11b
Revenue (TTM)HK$147.94m

12.5x

P/S Ratio

-0.9x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
2487 income statement (TTM)
RevenueCN¥137.62m
Cost of RevenueCN¥66.62m
Gross ProfitCN¥71.01m
Other ExpensesCN¥2.03b
Earnings-CN¥1.96b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-6.44
Gross Margin51.60%
Net Profit Margin-1,426.91%
Debt/Equity Ratio14.0%

How did 2487 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.